527 F.Supp.3d 562
S.D.N.Y.2021Background
- Blue Diamond’s almond packaging uses the prominent label “Smokehouse®” and red/red‑orange coloring; the ingredients panel lists “NATURAL HICKORY SMOKE FLAVOR.”
- Plaintiff Matthew Colpitts purchased the product in the Southern District of New York and alleges he relied on the packaging to believe the almonds were smoked (not merely flavored), paying a price premium (about $2.79/1.5 oz).
- Claims: violations of N.Y. Gen. Bus. Law §§ 349 and 350; common‑law fraud, negligent misrepresentation, breach of express and implied warranties, and unjust enrichment; plaintiff invoked CAFA jurisdiction.
- Defendant moved to dismiss for lack of Article III standing, for failure to plead a materially misleading practice or price‑premium injury, and because plaintiff allegedly seeks to privately enforce FDCA labeling rules; also attacked the common‑law claims for pleading defects.
- The Court held plaintiff has Article III standing and plausibly pleaded GBL §§ 349 and 350 claims (reasonable consumer could be misled by “Smokehouse®”); but dismissed all common‑law claims, MMWA claim, and injunctive relief with prejudice.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Article III standing | Colpitts alleges he purchased in reliance and would not have bought (or would have paid less) had he known the truth | No cognizable injury; failure to plead price‑premium injury | Standing satisfied: alleging purchase and lost value meets injury‑in‑fact for Article III |
| Violation of N.Y. G.B.L. §§ 349 & 350 (deceptiveness) | “Smokehouse®” and fire‑evocative coloring reasonably convey the product was smoked; back label is not expected reading | No reasonable consumer would infer actual smoking; plaintiff merely cites FDCA regs | GBL claims survive: reasonable consumer could be misled and materiality/price‑premium adequately alleged |
| Reliance on FDCA/regulatory violations | Alleges overlapping FDA labeling regulation but also makes independent deceptiveness allegations | Plaintiff is impermissibly trying to privately enforce FDCA/regulations (no private right) | Court rejects dismissal: plaintiff pleaded separate, free‑standing deceptive practices independent of FDCA citations |
| Fraud / scienter (common‑law fraud) | Labeling misled consumers; intent alleged by omission and profit motive | Dispositive: no particularized facts showing intent to deceive | Fraud dismissed with prejudice: Rule 9(b) not satisfied; no strong inference of scienter |
| Negligent misrepresentation / special relationship | Defendant presented itself as product expert; plaintiff relied on those representations | No special relationship between ordinary consumer and manufacturer/retailer | Dismissed with prejudice: no unique expertise or special relationship pleaded |
| Breach of express and implied warranties | Front label warranted smoked almonds; plaintiff will/has provide(d) notice | Plaintiff failed to give pre‑suit notice; no privity for implied warranty | Both warranty claims dismissed with prejudice: no adequate notice and lack of privity for implied warranty |
| Unjust enrichment | Defendant was unjustly enriched by premium price paid | Claim duplicates statutory/common‑law claims | Dismissed with prejudice as duplicative of other claims |
Key Cases Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility pleading standard for Rule 12(b)(6))
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (conclusory allegations insufficient under Rule 12(b)(6))
- Tsirelman v. Daines, 794 F.3d 310 (2d Cir. 2015) (district court must accept complaint allegations as true at motion to dismiss)
- Orlander v. Staples, Inc., 802 F.3d 289 (2d Cir. 2015) (elements of N.Y. G.B.L. §§ 349/350 and requirement to allege injury/lack of full value)
- Mantikas v. Kellogg Co., 910 F.3d 633 (2d Cir. 2018) (front‑of‑package representations are assessed in context; consumers need not be expected to consult back label to cure deception)
- Nick’s Garage, Inc. v. Progressive Cas. Ins. Co., 875 F.3d 107 (2d Cir. 2017) (GBL claim viable when a free‑standing deceptive practice overlaps federal regulation)
- PDK Labs, Inc. v. Friedlander, 103 F.3d 1105 (2d Cir. 1997) (no private right of action under FDCA; limits using FDCA as standalone private cause)
- Eternity Glob. Master Fund, Ltd. v. Morgan Guar. Tr. Co. of N.Y., 375 F.3d 168 (2d Cir. 2004) (Rule 9(b) particularity requirements for fraud pleading)
- Lerner v. Fleet Bank, N.A., 459 F.3d 273 (2d Cir. 2006) (showing strong inference of fraudulent intent by motive/opportunity or conscious recklessness)
- Aetna Cas. & Sur. Co. v. Aniero Concrete Co., 404 F.3d 566 (2d Cir. 2005) (conclusory scienter allegations may suffice only if supported by facts creating a strong inference of intent)